Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
For BMI above 40, comparison between GLP-1 therapy and bariatric surgery involves weighing multiple factors including health status, personal preferences, and long-term management considerations
PubMed Jensen, L., Helleberg, H., Roffel, A., van Lier, J.J.,Bjrnsdottir, I., Pedersen, P.J., Rowe, E., Derving Karsbl, J., & Pedersen, M.L
Lotte Bjerre Knudsen (34:01): Yeah, no, you do not have to be obese
At a minimum, a good follow-up should include: A clear dose-escalation plan Defined nutrition targets, especially protein Monitoring for known risks A long-term maintenance strategy Bottom line You deserve an evidence-based care plan that is clearly documented and tailored to your health goals
On April 1, 2026, the FDA approved orforglipron (Foundayo) by Eli Lilly for adults with obesity or overweight who also have weight-related medical problems to reduce excess body weight and maintain weight reduction long term, alongside a reduced-calorie diet and increased physical activity
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
